Erasca, Inc. (ERAS) Social Stream



Erasca, Inc. (ERAS): $5.82

0.25 (+4.49%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ERAS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 398

in industry

Erasca Inc (ERAS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ERAS.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 5 $45 $25 $30.2 $9.7 211.34%
2021-11-17 5 $45 $25 $30.8 $9.7 217.53%
2022-01-31 5 $45 $19 $29.6 $9.7 205.15%

The Trend in the Analyst Price Target


ERAS's average price target has moved down $0.6 over the prior 95 days.

Over the past 156 days, ERAS's average upside potential has been 48.07%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-28 3 28 25 26.5 23.01 15.17%
2021-09-11 3 28 25 26.5 21.02 26.07%
2021-09-18 3 28 25 26.5 19.42 36.46%
2021-09-19 3 28 25 26.5 19.42 36.46%
2022-01-31 5 45 19 29.6 11.85 149.79%

ERAS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.4 4 0 1 0 0 5

The Trend in the Broker Recommendations


ERAS's average broker recommendation rating improved by 0.35 over the prior 122 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ERAS as an investment opportunity.

  • In the context of all US stocks, Erasca Inc's upside potential (average analyst target price relative to current price) is higher than 267.3% of them.
  • Erasca Inc's variance in analysts' estimates is lower than -148.57% of all US stocks.
  • In the context of stocks in the mid market cap category, Erasca Inc's number of analysts covering the stock is greater than 76.8% of them.
  • ERAS has a higher average analyst price target than 104.85% of stocks in the mid market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Erasca Inc are EQRX, EPZM, and ENTA.

What is the outlook for ERAS? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3501 seconds.